A new model for the evaluation, introduction and reimbursement of new therapies against rare diagnoses

Denna rapport är en engelsk översättning av IHE Rapport 2023:5 (En ny modell för utvärdering, införande och ersättning av nya terapier mot sällsynta diagnoser).

In this IHE report the author has identified a number of conditions which lead to the fact that today’s methods of valuing medicines hardly lead us to a satisfactory understanding of the value of orphan medicines. The insurance value is not included. The value of hope is not included, Process-related benefits are not included. The international discussion of how to make the valuation methods more in line with economic theory and including individual preferences are reported and ends up in suggestions for improvements.

Ladda ner den svenska rapporten
IHE Rapport 2023_5_

För mer information om rapporten kontakta Ulf Persson

IHE Report 2023:5b, IHE: Lund, Sweden